Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6986 results

Sort By:

A Community Health Education Intervention for Increasing Community-driven Actions to Reduce the Cancer Burden in Western New York

Study ID: NCT06681077
Start Date: 2024-11-16
End Date: 2026-11-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Community Health Education

Survey Administration

Sponsor

Roswell Park Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

A Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)

Study ID: NCT06644781
Start Date: 2025-03-27
End Date: 2029-11-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

510

Intervention / Treatment

Ifinatamab deruxtecan

Docetaxel

Paclitaxel

Irinotecan hydrochloride (HCl)

Sponsor

Daiichi Sankyo

Source: clinicaltrials.gov

Share:
Add to list

Zanubrutinib and Venetoclax in CLL (ZANU-VEN)

Study ID: NCT05168930
Start Date: 2022-02-18
End Date: 2028-10-28
Study Type

Interventional

Study Phase

Phase2

No. of Participants

45

Intervention / Treatment

Venetoclax

Zanubrutinib

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer

Study ID: NCT05726292
Start Date: 2025-01-06
End Date: 2028-04-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

90

Intervention / Treatment

Relacorilant

Enzalutamide

Placebo (Sugar Pill)

Androgen Deprivation Therapy

Radical Prostatectomy

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

Talimogene Laherparepvec, Nivolumab and Trabectedin for Sarcoma

Study ID: NCT03886311
Start Date: 2019-05-15
End Date: 2031-07-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

Talimogene Laherparepvec 100000000 PFU/1 ML Injection Suspension [IMLYGIC]

Nivolumab IV Soln 100 MG/10ML

Trabectedin 0.25 MG/1 VIAL Intravenous Powder for Solution

Sponsor

Sarcoma Oncology Research Center, LLC

Source: clinicaltrials.gov

Share:
Add to list

A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPC

Study ID: NCT05849298
Start Date: 2024-01-03
End Date: 2030-05-18
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

AA6617

Ugh 17

Piflufolastat F 18

SCAR

ADT

Best supportive care

Sponsor

Novartis Pharmaceuticals

Source: clinicaltrials.gov

Share:
Add to list

Exercise Training and NR Supplementation Trial to Improve Fitness in AYA HCT Survivors

Study ID: NCT05194397
Start Date: 2023-02-23
End Date: 2026-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

80

Intervention / Treatment

Nicotinamide Riboside

Placebo

Exercise Intervention

Sponsor

Children's Hospital of Philadelphia

Source: clinicaltrials.gov

Share:
Add to list

Promoting Resilience in Women With Breast Cancer (PRISM -MBC)

Study ID: NCT06855654
Start Date: 2025-01-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

Promoting Resilience in Women with Breast Cancer (PRISM)

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Study of ADI-PEG 20 or Placebo Plus Gem and Doc in Previously Treated Subjects With Leiomyosarcoma (ARGSARC)

Study ID: NCT05712694
Start Date: 2023-11-29
End Date: 2027-12-30
Study Type

Interventional

Study Phase

Phase3

No. of Participants

300

Intervention / Treatment

ADI PEG20

Placebo

Sponsor

Polaris Group

Source: clinicaltrials.gov

Share:
Add to list

Evaluation of Depression and Anxiety in Chemotherapy Patients

Study ID: NCT03552731
Start Date: 2017-12-20
End Date: 2025-12-20
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Surveys

Sponsor

Richmond University Medical Center

Source: clinicaltrials.gov

Share:
Add to list